II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, D-81675 München, Germany.
Universitätsklinik für Innere Medizin I, Salzburger Landeskliniken, Universitätsklinikum Salzburg, Müllner Hauptstraße 48, A-5020 Salzburg, Austria.
J Zhejiang Univ Sci B. 2018 Jul;19(7):515-524. doi: 10.1631/jzus.B1700243.
Stroke volume variation (SVV) has high sensitivity and specificity in predicting fluid responsiveness. However, sinus rhythm (SR) and controlled mechanical ventilation (CV) are mandatory for their application. Several studies suggest a limited applicability of SVV in intensive care unit (ICU) patients. We hypothesized that the applicability of SVV might be different over time and within certain subgroups of ICU patients. Therefore, we analysed the prevalence of SR and CV in ICU patients during the first 24 h of PiCCO-monitoring (primary endpoint) and during the total ICU stay. We also investigated the applicability of SVV in the subgroups of patients with sepsis, cirrhosis, and acute pancreatitis.
The prevalence of SR and CV was documented immediately before 1241 thermodilution measurements in 88 patients.
In all measurements, SVV was applicable in about 24%. However, the applicability of SVV was time-dependent: the prevalence of both SR and CV was higher during the first 24 h compared to measurements thereafter (36.1% vs. 21.9%; P<0.001). Within different subgroups, the applicability during the first 24 h of monitoring ranged between 0% in acute pancreatitis, 25.5% in liver failure, and 48.9% in patients without pancreatitis, liver failure, pneumonia or sepsis.
The applicability of SVV in a predominantly medical ICU is only about 25%-35%. The prevalence of both mandatory criteria decreases over time during the ICU stay. Furthermore, the applicability is particularly low in patients with acute pancreatitis and liver failure.
每搏量变异度(SVV)在预测液体反应性方面具有较高的灵敏度和特异性。然而,其应用需要窦性节律(SR)和控制机械通气(CV)。一些研究表明,SVV 在重症监护病房(ICU)患者中的应用具有一定的局限性。我们假设 SVV 的适用性可能会随时间变化,并且在 ICU 患者的某些亚组中也存在差异。因此,我们分析了在 PiCCO 监测的前 24 小时内(主要终点)和整个 ICU 住院期间,SR 和 CV 在 ICU 患者中的发生率,并研究了 SVV 在败血症、肝硬化和急性胰腺炎患者亚组中的适用性。
在 88 例患者的 1241 次热稀释测量前,记录了 SR 和 CV 的发生率。
在所有测量中,SVV 的适用性约为 24%。然而,SVV 的适用性是时间依赖性的:与之后的测量相比,SR 和 CV 的发生率在最初 24 小时内更高(36.1%比 21.9%;P<0.001)。在不同的亚组中,监测的前 24 小时内的适用性在急性胰腺炎中为 0%,在肝功能衰竭中为 25.5%,在没有胰腺炎、肝功能衰竭、肺炎或败血症的患者中为 48.9%。
在以内科为主的 ICU 中,SVV 的适用性约为 25%-35%。在 ICU 住院期间,这两个必需条件的发生率随时间而降低。此外,在急性胰腺炎和肝功能衰竭患者中,适用性特别低。